Broadpeak (ALBPK) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
29 Oct, 2025Executive summary
Revenue grew 26.2% year-over-year in H1 2025, with acceleration in Q2 due to a major Cloud PVR contract with a European operator.
Recurring revenue accounted for 44.4% of total, reflecting a shift toward SaaS and maintenance.
Profitability improved significantly, with positive EBITDA of €0.8m versus a loss of €4.2m in H1 2024.
Net loss narrowed to €1.5m from €4.4m year-over-year.
Financial highlights
Revenue reached €21.7m, up from €17.2m in H1 2024.
Gross margin was €17.0m (78.6% of revenue), slightly down from 80.6% in H1 2024.
Adjusted EBITDA was €2.9m, compared to -€1.9m a year earlier.
Operating loss reduced to €2.9m from €6.6m.
Outlook and guidance
2025 targets: revenue growth and positive EBITDA reaffirmed.
2027 targets: revenue above €50m, 50% recurring revenue, and EBITDA margin around 15%.
Management expects continued sales momentum and innovation to support growth.
Latest events from Broadpeak
- Revenue up 12.7% to €44.4m, with SaaS and recurring sales fueling growth.ALBPK
H2 2025 TU19 Feb 2026 - Q3 revenue up 10.8% and nine-month sales up 21.0%, with strong recurring revenue growth.ALBPK
Q3 2025 TU4 Nov 2025 - Recurring revenue rose to 43.2% and gross margin to 80.6% despite a 5% sales drop.ALBPK
H1 202429 Oct 2025 - Q3 revenue rebounded 10% year-over-year, with recurring SaaS revenue driving growth.ALBPK
Q3 2024 TU29 Oct 2025 - Revenue down 5% in H1 2024; growth in Americas/EMEA, APAC rebound expected in Q3.ALBPK
H1 2024 TU29 Oct 2025 - 2024 saw a return to growth, higher margins, and positive cash flow, with SaaS momentum building.ALBPK
H2 202429 Oct 2025 - Revenue up 0.9% to €39.4m in 2024, with recurring revenues and EMEA driving growth.ALBPK
H2 2024 TU29 Oct 2025 - Q1 2025 revenue up 10.6%, recurring revenue surges 33%, 2027 targets reaffirmed.ALBPK
Q1 2025 TU29 Oct 2025 - Revenue up 26.2% in H1 2025, with strong SaaS growth and 2027 targets reaffirmed.ALBPK
H1 2025 TU29 Oct 2025